Ann: Annual General Meeting Addresses and Presentation, page-65

First 65 Last

Share
Profile

Follow
dbd25

6,535 Posts.

2437

22/05/24

12:34

Post #: 73953106
Share

Originally posted by Fact Finder: ↑

You do have to love the simplicity of the 100s of competitors all working on Ai about to burst onto the market and destroy shareholders wealth.

The problem with this simplistic argument is the complete failure to acknowledge that developing true Ai is not something that you can knock up in your garage in a couple of days.

Intel has been working on trying to do what Brainchip has done for many, many years and Loihi 1 and Loihi 2 are still only research chips and far from being commercialised as they are still incomplete technologies that Mike Davies has suggested could be up to 5 years away from being ready.

IBM has been working on trying to do what Brainchip has done for many, many years and yet True North still sits as a research chip in the lab and they have gone off in another direction abandoning the idea they will produce true Ai any year soon.

Brainchip's technology has been 15 years in the making.

Yet we are encouraged to worry that 100s of unnamed companies working on neuromorphic Ai will suddenly come to market with a commercially ready chip out of the blue that will leap ahead of AKD1000, AKD1500, AKIDA 2.0, TENNs and even AKIDA 3.0 which is currently in development and be so impressive that all of the companies currently partnered and trialling AKIDA technologies will say sorry we are going back to the drawing board because of these 100s of newly released technologies that are yet to be tested.

While competitors should always be considered and factored into investment decisions Brainchip is not selling chocolate bars it is selling the technology that will usher in the 4th Industrial Revolution and creating such technology is believe it or not something not just anyone can do it requires a significant level of genius.

My opinion only DYOR

Fact Finder

Expand

On page 17 of the last preso, they include this image under the title "TENNs exponentially reduces energy use"
I'm technically qualified, but I have no idea what this is about. No reputable technical journal would ever publish such an image, and I doubt anyone would want to include it in a conference presentation, or similar.
Does anyone know what this is supposed to represent ?

All IMHO, DYOR

BRN Price at posting: 25.5¢ Sentiment: None Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

MM1

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

GRE

Greentech finds lithium trend across 5.5 km at WA's Kobe South

I88

Infini soars 50% as company reveals it could’ve made uranium history – redefining what it means to be “high grade”

LGM

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

There are more pages in this discussion • 8 more messages in this thread...

First 65 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 20.0¢		Change 0.000(0.00%)		Mkt cap ! $357.2M

Open	High	Low	Value	Volume
20.0¢	20.5¢	19.3¢	$1.100M	5.574M

Buyers (Bids)

No.	Vol.	Price($)
21	296537	20.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.5¢	1046954	30

View Market Depth

No.	Vol.	Price($)
17	240986	0.200
29	1247601	0.195
69	2266621	0.190
32	1453391	0.185
55	1694980	0.180

Price($)	Vol.	No.
0.205	1046954	30
0.210	885720	19
0.215	584832	16
0.220	817003	22
0.225	590337	16

Last trade - 13.25pm 10/07/2024 (20 minute delay)

BRN (ASX) Chart

Ann: Annual General Meeting Addresses and Presentation, page-65

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Greentech finds lithium trend across 5.5 km at WA's Kobe South

Infini soars 50% as company reveals it could’ve made uranium history – redefining what it means to be “high grade”

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Annual General Meeting Addresses and Presentation, page-65

Top Stories

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Greentech finds lithium trend across 5.5 km at WA's Kobe South

Infini soars 50% as company reveals it could’ve made uranium history – redefining what it means to be “high grade”

Legacy shares jump on discovery of multiple epithermal veins at Bauloora JV

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News